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Accepted 1 November 2013The use of minimally invasive surgical techniques constitutes
the most important advance in reducing surgical morbidity in gy-
necologic oncology over the past 15 years. Patients treated lapa-
roscopically have less intraoperative blood loss, less postoperative
pain, and shorter hospital stays, compared to patients treated by
laparotomy [1]. The use of robotic surgery for the management of
gynecological malignancies allows cancer-bearing organs and tis-
sues to be removed using sophisticated surgeon-manipulated
minimally invasive robotic surgical instrumentation. Robotic sur-
gery has expanded the potential cohort of women eligible for
minimally invasive surgery such as obese patients and patients
with multiple comorbidities [2]. Robotic surgery is quickly replac-
ing traditional laparoscopy in many gynecologic oncology practices
because it can improve the quality of life of gynecologic cancer
patients by reducing surgical morbidity [3].
Kymerax device (Terumo Europe Espa~na SL, Madrid, Spain) is a
new robotic-driven, articulating, handheld laparoscopic device that
improves triangulation while preserving precise motions. This
system consists of a generator connected to interchangeable han-
dles and instruments. The Kymerax device (Terumo) was ﬁrst used
for gynecological surgery in 2012 [4], although we report the ﬁrst
clinical use of the Kymerax device (Terumo) in gynecological lap-
aroscopy for malignant disease. We present in this paper an un-
usual case of laparoscopic hysterectomy and bilateral
oophorectomy for uterine sarcoma treated by using this new
handheld robotic device.
A 59-year-old multipara woman with a body mass index of
25.4 kg/m2 presented at La Paz University Hospital (Madrid, Spain)
with postmenopausal metrorrhagia. Several years earlier, the pa-
tient had undergone a laparoscopic tubal ligation and a* Corresponding author. Gynecologic Oncology Unit, La Paz University Hospital,
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phy revealed moderate endometrial thickening. A hysteroscopy
revealed a 3-cm polypwith hemorrhagic changes. The biopsy of the
polyp showed a low-grade endometrial stromal sarcoma with ne-
crosis and the following tumor markers: positive for CD10, WT1,
and vimentin; negative for actin, desmin, and cytokeratin; positive
for estrogen and progesterone receptors and for Ki67 (20%). The
computed tomography scan and magnetic resonance imaging
showed an endometrial lesion on the left horn of the uterus, but no
secondary extension. Findings were compatible with a Interna-
tional Federation of Gynecology and Obstetrics (FIGO) stage IA
endometrial neoplasm [5].
The patient underwent a laparoscopic hysterectomy and bilat-
eral oophorectomy using three 12-mm ports (1 for the umbilical
and 1 in each ﬂank), a RUMI uterine manipulator (Cooper Surgical,
Shelton, CT, USA), monopolar scissors, bipolar forceps, and hand-
held robotic device. The vaginal cuff closure was performed by 0-
Vicryl running sutures with intracorporeal knots using the new
handheld robotic device (Figs. 1 and 2). The surgery time was 80
minutes and the estimated blood loss was 180 mL. The pathologyFig. 1. Vaginal cuff suturing with the handheld robotic device.
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Fig. 2. The Kymerax device allows for a more accurate positioning of the needle, which
cannot be achieved with traditional instruments for certain procedures such as during
vaginal cuff suturing.
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mal sarcoma. Her postoperative recovery was uneventful and the
patient was discharged 48 hours after the surgery. After 13 months
of follow-up, the patient remains asymptomatic.
The Kymerax device (Terumo) is used for laparoscopic surgery
and provides some beneﬁts, compared to traditional laparoscopic
instruments such asmore precisemovements because of its greater
ﬂexibility. This devicemay also allow for a faster surgical procedure.
In addition, the increased maneuverability permits easier access to
otherwise difﬁcult areas, thereby reducing the risk of potential
mistakes and complications. These factors may all result in a
reduced hospital stay.
This robotic device has already been successfully used in uro-
logical surgery. Its ﬁrst clinical use in benign gynecological surgery
has been recently publisheddlast year, Hackethal and colleagues[4] performed a laparoscopic hysterectomy in a patient with a
medical history of benign metrorrhagia.
The Kymerax device (Terumo) uses 12-mm ports, although this
has no effect on postoperative pain, hospitalization time, or es-
thetics outcomes. The operative time in our patient was 80 mi-
nutes, which is comparable to the time required for conventional
laparoscopy (75 ± 21 minutes), but less than the time for robotics
surgery (106 ± 29 minutes) [6].
To our knowledge, this is the ﬁrst clinical use of the Kymerax
device (Terumo) for the management of malignant pathology in
gynecological laparoscopy. We found this device useful for onco-
logical procedures because it allowed for more accurate move-
ments and better results in a complex surgery. This device
facilitated intracorporeal suturing with the same surgery time and
characteristics of conventional laparoscopy.
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